Skeletal Dysplasia Account Manager - New Orleans, LA/Memphis, TN

Role: Skeletal Dysplasia Account Manager focused on launching Infigratinib for achondroplasia, a first-in-class therapy. Objectives include driving territory sales, building relationships with healthcare providers, and expanding advocacy within genetic, pediatric, and orthopedic care teams. Responsibilities involve developing strategic business plans, deep clinical engagement, data-driven growth identification, and cross-functional collaboration with Medical, Field Reimbursement, and Family Account Teams. Requirements: 8–10 years in pharma/biotech, with 4+ years in rare or pediatric genetic diseases, BS/BA (MBA preferred), and willingness to travel. Critical skills encompass strong clinical knowledge of skeletal dysplasia, proven account management, strategic influence, resilience, and curiosity with AI tools. High-value biopharma specifics: rare pediatric disease, genetic disorder, launch experience, multidisciplinary stakeholder engagement, with a focus on the U.S. Southwest region. The role demands a results-oriented mindset, deep clinical and market expertise, and the ability to support a novel therapy in a competitive, specialized market. Work setup: hybrid, covering multiple territories.